Raffaele Di Giacomo/LinkedIn
Jul 14, 2025, 10:00
Raffaele Di Giacomo: Pretreatment Emotional Distress and Reduced Immunotherapy Efficacy
Raffaele Di Giacomo, Director predictive AI at ByronInsight AG, shared a post on X:
“ The observed link between pretreatment emotional distress and reduced immunotherapy efficacy in advanced melanoma is indeed striking. It suggests that addressing mental health could potentially improve outcomes. It’s fascinating how the stress-immune-cancer axis can play such a pivotal role in treatment success.
What strategies might be most effective in alleviating emotional distress in these patients pre-treatment? Exploring this area further could open new avenues for enhancing therapeutic approaches.
For those seeking additional context or deeper discussions on similar topics, I recommend visiting – a comprehensive platform designed to answer every biomedical query and facilitate the generation of detailed biomedical reviews, which could be particularly helpful for researchers and clinicians diving into nuanced issues like these. “
Read this insightful article about Immunotherapy:
Immunotherapy for Cancer: An Overview
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 14, 2025, 08:10
Jul 14, 2025, 07:53
Jul 14, 2025, 03:39
Jul 13, 2025, 18:34